The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Amphotericin primarily kills yeast by simply binding ergosterol
Open accessAbstract
Amphotericin B (AmB) is a prototypical small molecule natural product that can form ion channels in living eukaryotic cells and has remained refractory to microbial resistance despite extensive clinical utilization in the treatment of life-threatening fungal infections for more than half a century. It is now widely accepted that AmB kills yeast primarily via channel-mediated membrane permeabilization. Enabled by the iterative cross-coupling-based synthesis of a functional group deficient derivative of this natural product, we have discovered that channel formation is not required for potent fungicidal activity. Alternatively, AmB primarily kills yeast by simply binding ergosterol, a lipid that is vital for many aspects of yeast cell physiology. Membrane permeabilization via channel formation represents a second complementary mechanism that further increases drug potency and the rate of yeast killing. Collectively, these findings ( i ) reveal that the binding of a physiologically important microbial lipid is a powerful and clinically validated antimicrobial strategy that may be inherently refractory to resistance, ( ii ) illuminate a more straightforward path to an improved therapeutic index for this clinically vital but also highly toxic antifungal agent, and ( iii ) suggest that the capacity for AmB to form protein-like ion channels might be separable from its cytocidal effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AmB binds to ergosterol, forming microporous channels on the cell membrane and enabling the drug’s fungicidal activity.”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Downregulation of ergosterol may therefore reduce the exposure of AmB drug targets [64].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [64]
In the citing paper
“These amphipathic compounds act as a sponge extracting ergosterol from the fungal cell membrane, leading to the formation of pores, causing leakage of cellular components and ultimately death of the fungal cell [32,33].”
From Antifungal therapy of Candida biofilms: Past, present and future (2023) · cites this paper as [33]
In the citing paper
“Amphotericin B (AMB), a polyene class of antifungal drug, irreversibly binds to ergosterol, resulting in fungal cell death.”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [615]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry
Ejsing, C. S., Sampaio, J. L., Surendranath, V., Duchoslav, E., Ekroos, K., Klemm, R. W., Simons, K., & Shevchenko, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811700106 · Cited by 1,053
Antibacterial agents based on the cyclic d,l-α-peptide architecture
Fernandez‐Lopez, S., Kim, H.-S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A. B., Kraehenbuehl, K., Long, G. V., Weinberger, D. A., Wilcoxen, K., et al. (2001) · Nature · doi:10.1038/35086601 · Cited by 938
Taubes, G. (2008) · Science · doi:10.1126/science.321.5887.356 · Cited by 757
How do the polyene macrolide antibiotics affect the cellular membrane properties?
Bolard, J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(86)90002-x · Cited by 757
KRUIJFF, B. D., & DEMEL, R. A. (1974) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(74)90332-0 · Cited by 609
Knapp, D. M., Gillis, E. P., & Burke, M. D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901416p · Cited by 559
Self-citationAn Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, L., Hillman, J. D., Zachariah, C., Kuipers, O. P., KRUIJFF, B. D., & Breukink, E. J. (2006) · Science · doi:10.1126/science.1129818 · Cited by 502
Gillis, E. P., & Burke, M. D. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0716204 · Cited by 488
Self-citation
Cited by
Sorted by citations
Items 301–400 of 612
Multi-Phase Solvation Model for Biological Membranes: Molecular Action Mechanism of Amphotericin B
Falcón-González, J. M., Jiménez-Domínguez, G., Ortega‐Blake, I., & Carrillo‐Tripp, M. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00337 · Cited by 16
Zielińska, J., Wieczór, M., Chodnicki, P., Grela, E., Luchowski, R., Nierzwicki, Ł., Bączek, T., Gruszecki, W. I., & Czub, J. (2020) · Nanoscale · doi:10.1039/d0nr07707k · Cited by 15
Alligamycin A, an antifungal β-lactone spiroketal macrolide from Streptomyces iranensis
Yang, Z., Qiao, Y., Strøbech, E., Morth, J. P., Walther, G., Jørgensen, T. S., Lum, K. Y., Peschel, G., Rosenbaum, M. A., Previtali, V., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53695-3 · Cited by 15
A sponge against fungal infections
Lohner, K. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1518 · Cited by 15
Alvarez, C., Andes, D. R., Kang, J. Y., Krug, C., & Kwon, G. S. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2121-7 · Cited by 15
Kesarwani, V., Kelly, H. G., Shankar, M., Robinson, K. J., Kent, S. J., Traven, A., & Corrie, S. R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10853 · Cited by 15
Vij, R., Hube, B., & Brunke, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.003 · Cited by 15
Antifungal Use in Veterinary Practice and Emergence of Resistance
Seyedmousavi, S., Wiederhold, N. P., Ebel, F., Hedayati, M. T., Rafati, H., & Verweij, P. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-72093-7_16 · Cited by 15
Alonso, L., Mendanha, S. A., Dorta, M. L., & Alonso, A. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c07721 · Cited by 15
Healthcare-associated fungal infections and emerging pathogens during the COVID-19 pandemic
Shah, K., Deshpande, M., & Shah, P. (2024) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2024.1339911 · Cited by 14
Kokona, B., Winesett, E. S., von Krusenstiern, A. N., Cryle, M. J., Fairman, R., & Charkoudian, L. K. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.11.011 · Cited by 14
Amphotericin B-copper(II) complex shows improved therapeutic index in vitro
Chudzik, B., Czernel, G., Miaskowski, A., & Gagoś, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.040 · Cited by 14
Soeiro, V. S., Silva-Carvalho, R., Martins, D., Parpot, P., Grotto, D., Chaud, M. V., Gama, M., & Jozala, Â. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-03264-1 · Cited by 14
Won, T., Mohid, S. A., Choi, J., Kim, M., Krishnamoorthy, J., Biswas, I., Bhunia, A., & Lee, D. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.106981 · Cited by 14
Chiu, Y., Huang, C., & Shigeto, S. (2013) · ChemBioChem · doi:10.1002/cbic.201300096 · Cited by 14
Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin
Teixeira‐Santos, R., Ricardo, E., Branco, R. J. F., Azevedo, M. M., Rodrigues, A. G., & Pina‐Vaz, C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01439 · Cited by 14
Won, H.-J., Kim, H.-J., Jang, J., Kang, S.-H., Choi, S.-S., & Kim, E. (2017) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-017-1954-8 · Cited by 14
Molecular Umbrellas Modulate the Selective Toxicity of Polyene Macrolide Antifungals
Skwarecki, A. S., Skarbek, K., Martynow, D., Serocki, M., Bylińska, I., Milewska, M. J., & Milewski, S. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00136 · Cited by 14
Keniya, M. V., Ruma, Y. N., Tyndall, J. D. A., & Monk, B. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01131-18 · Cited by 14
Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin
Wong, J. H., Alfatah, M., Kong, K. W., Hoon, S. S., Yeo, W. L., Ching, K. C., Goh, C. J. H., Zhang, M. M., Lim, Y. H., Wong, F. T., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218189 · Cited by 14
Applications of neutron reflectometry in biology
Gerelli, Y. (2020) · EPJ Web of Conferences · doi:10.1051/epjconf/202023604002 · Cited by 14
Müller, C., Binder, U., Maurer, E., Grimm, C. M., Giera, M. A., & Bracher, F. (2015) · Steroids · doi:10.1016/j.steroids.2015.05.004 · Cited by 14
Yamamoto, T., Umegawa, Y., Tsuchikawa, H., Matsumori, N., Hanashima, S., Murata, M., Haser, R., Rawlings, B. J., & Caffrey, P. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.009 · Cited by 14
Molecular Mechanisms of Resistance to Antifungals in Candida albicans
Ruiz‐Baca, E., Arredondo-Sánchez, R. I., Corral-Pérez, K., López-Rodríguez, A., Meneses‐Morales, I., Ayala‐García, V. M., & Martínez-Rocha, A. L. (2021) · Infectious diseases · doi:10.5772/intechopen.96346 · Cited by 15
Ions in motion: From biological channels to engineered transport systems
Wu, B., Yan, Y., Zhu, Y., Ji, C., Lin, Y., & Lang, C. (2025) · Giant · doi:10.1016/j.giant.2025.100352 · Cited by 13
Yang, S.-H., Chen, W., Shan, F., Jia, X.-Z., Deng, R., Tang, C.-P., & Shen, Z. (2017) · Chinese Herbal Medicines · doi:10.1016/s1674-6384(17)60077-7 · Cited by 13
Candida Biofilm Tolerance: Comparison of Planktonic and Biofilm Resistance Mechanisms
Dominguez, E. G., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_6 · Cited by 14
Самедова, А. А., Tagi-zade, T. P., & Kasumov, K. M. (2018) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162018030135 · Cited by 13
Liu, L. L., Jiang, T., Zhou, J., Mei, Y., Li, J., Tan, J.-C., Wei, L., Li, J., Peng, Y., Chen, C., et al. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13814 · Cited by 12
Jafari, M., Abolmaali, S. S., Borandeh, S., Najafi, H., Zareshahrabadi, Z., Heidari, R., Azarpira, N., Zomorodian, K., & Tamaddon, A. M. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212996 · Cited by 13
Chulkov, E. G., Efimova, S. S., Schagina, L. V., & Ostroumova, O. S. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.07.008 · Cited by 13
Imai, H., Fujita, T., Kajiya, M., Ouhara, K., Yoshimoto, T., Matsuda, S., Takeda, K., & Kurihara, H. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447877 · Cited by 13
Cai, Z., Chai, Y., Zhang, C., Feng, R., Sang, H., & Lü, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00106 · Cited by 13
Nitrogen concentration affects amphotericin B and fluconazole tolerance of pathogenic cryptococci
Bosch, C., Toplis, B., Vreulink, J.-M., Volschenk, H., & Botha, A. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa010 · Cited by 12
Klaps, J., de Vega, C., Herrera, C. M., Junker, R. R., Lievens, B., & Álvarez‐Pérez, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240093 · Cited by 12
Laraia, L., Garivet, G., Foley, D. J., Kaiser, N., Müller, S., Zinken, S., Pinkert, T., Wilke, J., Corkery, D., Pahl, A., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201913712 · Cited by 12
Hussain, S., Ali, M., Ghazy, A. I., Al-Doss, A., Attia, K. A., Shah, T. A., & Li, F. (2025) · Chemical and Biological Technologies in Agriculture · doi:10.1186/s40538-025-00744-8 · Cited by 12
Sztafrowski, D., Suchodolski, J., Muraszko, J., Sigler, K., & Krasowska, A. (2019) · Folia Microbiologica · doi:10.1007/s12223-019-00686-3 · Cited by 12
Zhang, C., Ren, Y., Gao, L., Gu, H., & Lü, L. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.02571-20 · Cited by 13
Zhang, J., Gong, H., Liao, M., Li, Z., Schweins, R., Penny, J. I., & Lu, J. R. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.170 · Cited by 12
Eliaš, D., Hervay, N. T., Bujdoš, M., & Gbelská, Y. (2023) · Journal of Fungi · doi:10.3390/jof9050579 · Cited by 12
Emerging Role of Sphingolipids in Amphotericin B Drug Resistance
Madaan, K., & Bari, V. K. (2023) · Microbial Drug Resistance · doi:10.1089/mdr.2022.0353 · Cited by 12
Simple Strategy for Taming Membrane-Disrupting Antibiotics
Yu, Y., Sabulski, M. J., Schell, W. A., Pires, M. M., Perfect, J. R., & Regen, S. L. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00629 · Cited by 12
Sterol targeting drugs reveal life cycle stage-specific differences in trypanosome lipid rafts
Sharma, A. I., Olson, C. L., Mamede, J. I., Gazos‐Lopes, F., Epting, C. L., de Almeida, I. C., & Engman, D. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-08770-9 · Cited by 13
Khan, D., Nile, A. H., Tripathi, A., & Bankaitis, V. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136754 · Cited by 11
Dumoulin, P. C., Vollrath, J., Won, M. M., Wang, J. X., & Burleigh, B. A. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.937910 · Cited by 12
Tezcan, E. F., Demirtas, Y., Çakar, Z. P., & Ülgen, K. Ö. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1121409 · Cited by 11
Combating increased antifungal drug resistance in Cryptococcus, what should we do in the future?
Deng, H., Song, J., Huang, Y., Yang, C., Zang, X., Zhou, Y., Li, H., Dai, B., & Xue, X. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023011 · Cited by 12
Tosyalı, Ö. A., Şahin, F., Çetin, Y., & Karal‐Yılmaz, O. (2024) · Journal of Applied Polymer Science · doi:10.1002/app.56517 · Cited by 11
Abirami, M., Kumar, B. K., Faheem, F., Dey, S., Johri, S., Reguera, R. M., Balaña‐Fouce, R., Sekhar, K. V. G. C., & Murugesan, S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115471 · Cited by 11
Bozlak, Ç. E. B., Ercan, İ., Işık, E., Şahin, E., Balcioglu, O., Kodedová, M., Zimmermannová, O., Dündar, M., Sychrová, H., & Koç, A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02268-18 · Cited by 11
Simm, C., Lee, T.-H., Weerasinghe, H., Walsh, D., Nakou, I. T., Shankar, M., Tse, W. C., Zhang, Y. L., Inman, R., Mulder, R. J., et al. (2024) · mBio · doi:10.1128/mbio.02611-24 · Cited by 11
New Insights Regarding Yeast Survival following Exposure to Liposomal Amphotericin B
Teixeira‐Santos, R., Ricardo, E., Guerreiro, S. G., Costa‐de‐Oliveira, S., Rodrigues, A. G., & Pina‐Vaz, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00575-15 · Cited by 10
BSC2 enhances cell resistance to AmB by inhibiting oxidative damage in Saccharomyces cerevisiae
Kong, Y., Wang, Q., Cao, F., Zhang, X., Fang, Z., Shi, P., Wang, H., Shen, Y., & Huang, Z. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1751151 · Cited by 11
Balance between Exocytosis and Endocytosis Determines the Efficacy of Sterol-Targeting Antibiotics
Nishimura, S., Tokukura, M., Ochi, J., Yoshida, M., & Kakeya, H. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.10.014 · Cited by 10
Lewis, R. A., Li, J., Allenby, N., Errington, J., Hayles, J., & Nurse, P. (2017) · Journal of Cell Science · doi:10.1242/jcs.194571 · Cited by 10
Green, R. M., & Bicker, K. L. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00327 · Cited by 10
Engineering Telodendrimer Nanocarriers for Monomeric Amphotericin B Delivery
Ji, X., Shi, C., Guo, D., Yang, X., Suo, L., & Luo, J. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01087 · Cited by 10
Analysis of HIV-1 envelope cytoplasmic tail effects on viral replication
Alfadhli, A., Romanaggi, C., Barklis, R. L., & Barklis, E. (2023) · Virology · doi:10.1016/j.virol.2022.12.017 · Cited by 9
Druggable Sterol Metabolizing Enzymes in Infectious Diseases: Cell Targets to Therapeutic Leads
Nes, W. D., Chaudhuri, M., & Leaver, D. J. (2024) · Biomolecules · doi:10.3390/biom14030249 · Cited by 9
Forrester, S. J., Siefert, K., Ashwin, H. M., Brown, N., Zelmar, A., James, S. R., Lagos, D., Timmis, J., Chatterjee, M., Mottram, J. C., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15606.1 · Cited by 9
Ma, H., Qian, A., Zheng, Y., Meng, X., Wang, T., Zhang, Y., Sun, L., Zou, F., Zhao, B., Zhang, S., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02227 · Cited by 11
Chen, M., Shi, G., Dai, Y., Fang, W., & Wu, Q. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1133593 · Cited by 10
Rząd, K., Gabriel, I., Paluszkiewicz, E., Kuplińska, A., Olszewski, M., Chylewska, A., Dąbrowska, A., & Kozłowska-Tylingo, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-54252-0 · Cited by 9
Imai, H., Fujita, T., Kajiya, M., Ouhara, K., Miyagawa, T., Matsuda, S., Shiba, H., & Kurihara, H. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.07.001 · Cited by 9
de Oliveira, D. M., Furtado, F. B., Gomes, A. A. S., Belut, B. R., Nascimento, E. A., Morais, S. A. L., Martins, C. H. G., dos Santos, V. C. O., da Silva, C. V., Teixeira, T. L., et al. (2020) · ACS Omega · doi:10.1021/acsomega.9b01962 · Cited by 9
Flores-Romero, J. D., Rodríguez-Lozada, J., López‐Ortíz, M., Magaña, R., Ortega‐Blake, I., Regla, I., & Fernández‐Zertuche, M. (2016) · Organic Process Research & Development · doi:10.1021/acs.oprd.6b00211 · Cited by 9
Surface-grafted antimicrobial drugs: Possible misinterpretation of mechanism of action
Naderi, J., Giles, C., Saboohi, S., Griesser, H. J., & Coad, B. R. (2018) · Biointerphases · doi:10.1116/1.5050043 · Cited by 10
Antifungal persistence: Clinical relevance and mechanisms
Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H. (2025) · PLoS pathogens · doi:10.1371/journal.ppat.1013456 · Cited by 12
Blancett, L. T., Runge, K. A., Reyes, G. M., Kennedy, L., Jackson, S. C., Scheuermann, S. E., Harmon, M. B., Williams, J. C., & Shearer, G. (2021) · Journal of Fungi · doi:10.3390/jof7110981 · Cited by 11
Han, C.-Y., Jang, J., Kim, H.-J., Choi, S.-S., & Kim, E. (2019) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-019-02149-7 · Cited by 8
Burkin, M. A., Surovoy, Y. A., Arzumanian, V. G., & Galvidis, I. A. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.114875 · Cited by 8
Deciphering the Biological Activities of Antifungal Agents with Chemical Probes
Fridman, M., & Sakurai, K. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202211927 · Cited by 10
Dalhoff, A. (2017) · Clinical Microbiology Open Access · doi:10.4172/2327-5073.1000287 · Cited by 8
Repurposing benzimidazoles to fight Cryptococcus
de Oliveira, H. C., & Rodrigues, M. L. (2021) · Fungal Biology Reviews · doi:10.1016/j.fbr.2021.04.002 · Cited by 8
AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability
Vanzolini, T., Mambro, T. D., Magnani, M., & Menotta, M. (2023) · RSC Advances · doi:10.1039/d2ra07217c · Cited by 8
Hamann, L. G. (2014) · Nature Chemistry · doi:10.1038/nchem.1964 · Cited by 8
Boukari, K., Balme, S., Janot, J., & Picaud, F. (2015) · The Journal of Membrane Biology · doi:10.1007/s00232-015-9865-y · Cited by 8
Unique aggregation of conjugated amphotericin B and its interaction with lipid membranes
Kagan, S. A., Ickowicz, D. E., Domb, A. J., Dagan, A., & Polacheck, I. (2016) · Medical Mycology · doi:10.1093/mmy/myw099 · Cited by 8
Cryptococcus and Cryptococcosis
Godinho, R. M. D. C., Oliveira, D. L., Albuquerque, P. C., Dutra, F. F., Almeida‐Paes, R., Rodrigues, M. L., & Fonseca, F. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_6 · Cited by 8
Barreales, E. G., Rumbero, Á., Payero, T. D., de Pedro, A., Jambrina, E., & Aparicio, J. F. (2020) · Antibiotics · doi:10.3390/antibiotics9070413 · Cited by 9
Natamycin - antimycotic of polyene macrolides class with unusual properties
Малова, И. О., & Petrunin, D. D. (2015) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2015-91-3-161-184 · Cited by 13
Chemotherapy of Leishmaniasis: A Veterinary Perspective
Corral, M. J., & Alunda, J. M. (2013) · doi:10.1002/9783527670383.ch2 · Cited by 8
Ergosterol promotes aggregation of natamycin in the yeast plasma membrane
Szomek, M., Akkerman, V., Lauritsen, L., Walther, H.-L., Juhl, A. D., Thaysen, K., Egebjerg, J. M., Covey, D. F., Lehmann, M., Wessig, P., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184350 · Cited by 8
Deciphering the multidrug resistance paradigm in Candida auris
Santana, D. J., Cauldron, N. C., Rogers, P. D., & Cuomo, C. A. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01062-24 · Cited by 9
ASPECTOS CLÍNICOS E FATORES DE VIRULÊNCIA DE Malassezia spp
da Rocha, M. G., Pergentino, M. L. M., Aguiar, A. L. R., Costa, A. D. C., Martins, D. V., Araújo, G. D. S., de Aguiar, L., Pereira, L. M. G., Lopes, R. G. P., da Graça-Filho, R. V., et al. (2022) · Editora In Vivo eBooks · doi:10.47242/978-65-87959-13-9-4 · Cited by 6
Fonseca, X. M. Q. C., Costa, A. D. C., Aguiar, A. L. R., Martins, D. V., Araújo, G. D. S., de Aguiar, L., Pereira, L. M. G., da Rocha, M. G., Pergentino, M. L. M., Lopes, R. G. P., et al. (2022) · Editora In Vivo eBooks · doi:10.47242/978-65-87959-13-9-5 · Cited by 6
O GÊNERO Trichosporon: ASPECTOS GERAIS
Pereira, L. M. G., Aguiar, A. L. R., Costa, A. D. C., Martins, D. V., Araújo, G. D. S., de Aguiar, L., da Rocha, M. G., Pergentino, M. L. M., Lopes, R. G. P., da Graça-Filho, R. V., et al. (2022) · Editora In Vivo eBooks · doi:10.47242/978-65-87959-13-9-6 · Cited by 6
Impact of Nitric Oxide-Release Kinetics on Antifungal Activity
Grayton, Q. E., Conlon, I. L., Broberg, C. A., & Schoenfisch, M. H. (2024) · Journal of Fungi · doi:10.3390/jof10050308 · Cited by 8
David and Goliath: chemical perturbation of eukaryotes by bacteria
Ho, L., & Nodwell, J. R. (2015) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-015-1686-6 · Cited by 6
Park, H.-S., Kim, H., Han, C.-Y., Nah, H.-J., Choi, S.-S., & Kim, E. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00019 · Cited by 7
Amphotericin B still in the headlines
Romani, L. R. (2012) · Pathogens and Global Health · doi:10.1179/204777312x13419245939566 · Cited by 7
Pinheiro, A. M., Carreira, A., Prescott, T. A. K., Ferreira, R. B., & Monteiro, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01182 · Cited by 8
Alonso, L., Mendanha, S. A., Gomes, R. S., Dorta, M. L., & Alonso, A. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105859 · Cited by 7
Streekstra, H., Keuter, A., & Wilms, L. C. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.005 · Cited by 7
Glycosylated Polyene Macrolides Kill Fungi via a Conserved Sterol Sponge Mechanism of Action
Revie, N. M., & Cowen, L. E. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00520 · Cited by 8
Post-transcriptional control of antifungal resistance in human fungal pathogens
Sharma, C., & Kadosh, D. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2080527 · Cited by 6
Polyenic Antibiotics and Other Antifungal Compounds Produced by Hemolytic Streptomyces Species
Bobek, J., Filipová, E., Bergman, N., Čihák, M., Petřı́ček, M., Lara, A., Krištůfek, V., Megyes, M., Wurzer, T., Chroňáková, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315045 · Cited by 6
Wykrętowicz, K., Czyżewska-Dors, E. B., Dors, A., Pomorska‐Mól, M., Augustyniak, A., & Łagowski, D. (2025) · Animals · doi:10.3390/ani15223299 · Cited by 7
Serrano, R., González-Menéndez, V., Tormo, J. R., & Genilloud, O. (2023) · Journal of Fungi · doi:10.3390/jof9090883 · Cited by 6
Metadata
- Authors
- Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., & Burke, M. D.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-01-17
- Volume
- 109
- Issue
- 7
- Pages
- 2234-2239
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3289339
- OpenAlex
- W1987640473
- Cited by
- 608
- References
- 50
- Citations by year
- 2026: 42 · 2025: 42 · 2024: 34 · 2023: 49 · 2022: 45 · 2021: 56 · 2020: 53 · 2019: 50 · 2018: 32 · 2017: 44 · 2016: 44 · 2015: 40 · 2014: 36 · 2013: 30 · 2012: 11
- FWCI
- 24.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Bristol-Myers Squibb
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM080436, GM080436)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- amphotericin B, ergosterol binding, yeast cell death, antifungal mechanism, ion channel formation, membrane permeabilization, fungal drug resistance, natural product derivatives, therapeutic index, antifungal toxicity
- MeSH terms
- Amphotericin B, Antifungal Agents, Ergosterol, Saccharomyces cerevisiae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review